Research Topics
Species | D ArdissinoSummaryAffiliation: Ospedale Niguarda Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarctionPiera Angelica Merlini
IV Division of Cardiology, Ospedale Niguarda, Milan, Italy
Am J Cardiol 93:822-5. 2004....
Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stentingPiera Angelica Merlini
Division of Cardiology, Ospedale Niguarda, Piazza Ospedale Maggiore 1, 20162 Milan, Italy
Circulation 109:2203-6. 2004....
Mitral supravalvular ring: a case reportWalter Serra
Cardiology Division, Heart Department, Azienda Ospedaliera, Universitaria Parma, Italy
Cardiovasc Ultrasound 3:19. 2005..Cineangiography and MRI both failed in reaching this objective, whereas, transesophageal echocardiography is the best method to identify this congenital heart disease. Using TEE the identification is not only possible but also easier...
Tissue-factor antigen and activity in human coronary atherosclerotic plaquesD Ardissino
Division of Cardiology, IRCCS Policlinico San Matteo, Pavia, Italy
Lancet 349:769-71. 1997..Although plaque rupture or fissuring frequently occurs in atherosclerosis, only a small proportion of ruptured plaques develop thromboses...
Thrombogenic potential of human coronary atherosclerotic plaquesD Ardissino
Division of Cardiology, Ospedale Maggiore and University of Parma, Italy
Blood 98:2726-9. 2001..The higher tissue factor content found in plaques obtained from patients with unstable coronary disease was associated with a local increase in thrombin generation, thus suggesting a link with the in vivo thrombogenicity of the plaque...
Hemostatic markers and prognosis in ischemic heart diseaseP A Merlini
A De Gasperis Cardiology Department, Hospital Niguarda Ca Granda, Milan, Italy
Ital Heart J 2:499-501. 2001..The results of these studies as well as the value and applicability of new prothrombotic markers in the clinical practice are discussed...
Effect of abciximab on prothrombin activation and thrombin generation in patients with acute myocardial infarction also receiving reteplasePiera Angelica Merlini
Division of Cardiology, Ospedale Niguarda, Milan, Italy
Am J Cardiol 93:195-8. 2004....
Effect of Abciximab on prothrombin activation and thrombin generation in acute coronary syndromes without ST-segment elevation: Global Utilization of Strategies to Open Occluded Coronary Arteries Trial IV in Acute Coronary Syndromes (GUSTO IV ACS) ItalianPiera Angelica Merlini
Division of Cardiology, Ospedale Niguarda, Milan, Italy
Circulation 105:928-32. 2002..No data are available concerning the effect of abciximab on the in vivo markers of prothrombin activation and thrombin generation in patients with acute coronary syndromes without ST elevation...
In vivo thrombin generation and activity during and after intravenous infusion of heparin or recombinant hirudin in patients with unstable angina pectorisP A Merlini
Division of Cardiology, Ospedale Niguarda Ca Granda, Milan, Italy
Arterioscler Thromb Vasc Biol 20:2162-6. 2000..However, the inhibition of thrombin generation is not sustained, and after 1 month, the majority of patients have biochemical signs of increased thrombin generation...
Prognostic value of the admission electrocardiogram in acute coronary syndromesS Savonitto
Department of Cardiology A De Gasperis, Ospedale Niguarda Ca Granda, Milan, Italy
JAMA 281:707-13. 1999..The presence of ischemic changes on electrocardiogram (ECG) correlates with poorer outcomes in patients with acute chest pain...
Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trialS Savonitto
Department of Cardiology, Niguarda Hospital, Milan, Italy
Eur Heart J 24:1807-14. 2003....
Tissue factor in human coronary atherosclerotic plaquesD Ardissino
Division of Cardiology, I R C C S Policlinico San Matteo and University of Pavia, Piazza Golgi 1, 27100, Pavia, Italy
Clin Chim Acta 291:235-40. 2000..Variations in tissue factor content and activity may be responsible for the different thrombotic responses to human coronary atherosclerotic plaque rupture...
Laboratory markers of hypercoagulabilityM L Rossi
A De Gasperis Cardiology Department, Hospital Niguarda Ca Granda, Milan, Italy
Ital Heart J 2:490-4. 2001..The significance of these new assays and their role in defining a hypercoagulable state in different conditions are analyzed...
Effect of transdermal nitroglycerin or N-acetylcysteine, or both, in the long-term treatment of unstable angina pectorisD Ardissino
Division of Cardiology IRCCS Policlinico San Matteo, Pavia, Italy
J Am Coll Cardiol 29:941-7. 1997..This study was designed to evaluate whether the addition of transdermal nitroglycerin or oral N-acetylcysteine, or both, to conventional medical therapy improves the natural history of unstable angina pectoris...
The association of factor V Leiden with myocardial infarction is replicated in 1880 patients with premature diseaseP M Mannucci
Centro Emofilia e Trombosi A Bianchi Bonomi, Scientific Direction, IRCCS Fondazione Cà Granda Ospedale Maggiore, Universita degli Studi di Milano, Milan, Italy
J Thromb Haemost 8:2116-21. 2010....
Clinical, electrocardiographic, and biochemical data for immediate risk stratification in acute coronary syndromesS Savonitto
Dipartment of Cardiology Angelo De Gasperis, Niguarda Ca Granda Hospital, Milan, Italy
Ann Noninvasive Electrocardiol 6:64-77. 2001..However, how to best combine electrocardiographic and biochemical data for immediate risk stratification remains to be further elucidated...
Prothrombotic genetic markersM L Rossi
A De Gasperis Cardiology Department, Hospital Niguarda Ca Granda, Milan, Italy
Ital Heart J 2:495-8. 2001..In the present editorial, a comment on the studies already available is provided and the possible limitations of the present approach are analyzed...
Percutaneous coronary revascularisation in womenM L Rossi
Dipartimento Cardiologico A. De Gasperis, , Milan, Italy
Thromb Res 103:S105-11. 2001..Recent clinical trial have provided new insights into this problem. The influence on gender differences for the decision to undertake coronary angiography and percutaneous transluminal coronary angioplasty will be discussed...
Selection of drug therapy in stable angina pectorisS Savonitto
Second Division of Cardiology, Ospedale Niguarda Ca Granda, Milan, Italy
Cardiovasc Drugs Ther 12:197-210. 1998....
Long-term mortality in patients unsuitable for surgical revascularization undergoing elective left main coronary artery angioplastyL Vignali
Division of Cardiology, University Hospital of Parma, Parma, Italy
Minerva Cardioangiol 56:1-11. 2008..Secondary endpoints were to analyse long-term mortality in various categories (patients<75 years vs patients<75 years, males vs females, drug eluting stents [DES] vs bare metal stents [BMS])...
Genetic predisposition to atorvastatin-induced myopathy: a case reportM Francesca Notarangelo
Division of Cardiology, Azienda Ospedaliero Universitaria of Parma, Parma, Italy
J Clin Pharm Ther 37:604-6. 2012..Our objective is to report on two cases of statin-induced myopathy occurring in a family with two patients who are carriers of the loss of function SLCO1B1 genetic variant and to briefly review the related literature...
Different quantitative apoptotic traits in coronary atherosclerotic plaques from patients with stable angina pectoris and acute coronary syndromesMarco L Rossi
Division of Cardiology, Istituto Clinico Humanitas, Milan, Italy
Circulation 110:1767-73. 2004..We tested the hypothesis that apoptosis is quantitatively increased in unstable atherosclerotic plaques...
N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromesMarcello Galvani
Ospedale G B Morgagni and Fondazione Sacco, Forli, Italy
Circulation 110:128-34. 2004..We measured N-terminal pro-brain natriuretic peptide (NT-proBNP) on admission in patients with ACS and ECG evidence of myocardial ischemia...
Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI studyClaudio Cavallini
Ospedale Ca Foncello, Divisione di Cardiologia, Piazza Ospedale 1, 31100 Treviso, Italy
Eur Heart J 26:1494-8. 2005..In this multicentre prospective cohort study, we evaluated the influence of post-procedural elevations of CK-MB and troponin I (cTnI) on long-term mortality...
Tirofiban in acute coronary syndromesAlberto Menozzi
Division of Cardiology, Maggiore Hospital, University of Parma, Parma, Italy
Expert Rev Cardiovasc Ther 3:193-206. 2005..In particular, the role of early, upstream tirofiban coupled with early aggressive revascularization in the management of high-risk non-ST-segment elevation acute coronary syndromes is emphasized...
[Pathogenesis of acute coronary syndromes: the activated plaque]Giorgia Paoli
UO di Cardiologia, Ospedale Maggiore, Parma
Ital Heart J 6:5S-11S. 2005....
[Multivessel percutaneous coronary interventions. When incomplete revascularization may represent a therapeutic option]Fabrizio Ugo
UO Cardiologia, Dipartimento del Cuore, Azienda Ospedaliero Universitaria, Parma
G Ital Cardiol (Rome) 7:36S-46S. 2006....
[Low-molecular-weight heparins in acute coronary syndrome: acquired results and new perspectives]Fabrizio Ugo
U O di Cardiologia, Dipartimento del Cuore, Azienda Ospedaliero Universitaria Ospedale Maggiore, Parma
G Ital Cardiol (Rome) 7:771-9. 2006....
Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trialC Michael Gibson
Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
J Am Coll Cardiol 49:2238-46. 2007....
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromesJean-Pierre Bassand
Eur Heart J 28:1598-660. 2007
Prasugrel versus clopidogrel in patients with acute coronary syndromesStephen D Wiviott
Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
N Engl J Med 357:2001-15. 2007..Dual-antiplatelet therapy with aspirin and a thienopyridine is a cornerstone of treatment to prevent thrombotic complications of acute coronary syndromes and percutaneous coronary intervention...
Impact of acute renal failure following percutaneous coronary intervention on long-term mortalityAlberto Roghi
De Gasperis Department of Cardiology, Niguarda Ca Granda Hospital, Milan, Italy
J Cardiovasc Med (Hagerstown) 9:375-81. 2008..Whether this event should be considered as a marker of disease severity or an independent contributor to mortality is still unclear...
In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplastyGiuseppe Steffenino
Department of Cardiology, S Croce e Carle Hospital, Cuneo, Italy
Ital Heart J 5:136-45. 2004..The aim of this study was to observe the outcomes of high-risk patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis in a community setting...
Coagulation activation and long-term outcome in acute coronary syndromesDiego Ardissino
Division of Cardiology, Ospedale Niguarda Ca Grande, Milan
Blood 102:2731-5. 2003..25-2.28; RR, 1.35 and 95% CI, 1.11-1.86, respectively). After an episode of acute coronary syndrome, both high and low levels of thrombin generation are predictors of an increased risk of an unfavorable outcome...
One-year follow-up of the ASSENT-2 trial: a double-blind, randomized comparison of single-bolus tenecteplase and front-loaded alteplase in 16,949 patients with ST-elevation acute myocardial infarctionPeter Sinnaeve
Department of Cardiology, University of Leuven, Leuven, Belgium
Am Heart J 146:27-32. 2003..CONCLUSIONS: One year after randomization, mortality rates remain similar in patients with acute myocardial infarction treated with an accelerated infusion of alteplase or a single bolus of tenecteplase...
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trialMichael A Blazing
Duke Clinical Research Institute, Durham, NC, USA
JAMA 292:55-64. 2004..It is not clear if combining enoxaparin with glycoprotein IIb/IIIa inhibitors is as safe or as effective as the current standard combination of unfractionated heparin with glycoprotein IIb/IIIa inhibitors...
Association between admission white blood cell count and one-year mortality in patients with acute coronary syndromesMichael H Yen
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
Am J Med 115:318-21. 2003
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trialA Michael Lincoff
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA
JAMA 288:2130-5. 2002..Rates of nonfatal ischemic complications were significantly diminished...
[Acute coronary syndromes with ST-segment elevation: primary angioplasty]Giorgia Paoli
Dipartimento di Cardiologia, Ospedale Maggiore, Parma
Ital Heart J 4:16S-20S. 2003
Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-upDebabrata Mukherjee
Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, KY 40536 0200, USA
Eur Heart J 26:2524-8. 2005..We report here the 1-year mortality of the study population...
Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up studyDavid J Moliterno
Department of Cardiovascular Medicine and C5 Cleveland Clinic Cardiovascular Coordinating Center, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Lancet 360:355-60. 2002....
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living aloneRobert G Wilcox
Duke Clinical Research Institute, Durham, North Carolina, USA
Am J Cardiol 90:1374-7. 2002
Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of CardiologyFrans Van de Werf
Cardiology, Gasthuisberg University Hospital, Leuven, Belgium
Eur Heart J 24:28-66. 2003
Effectiveness of adjunctive stent implantation following directional coronary atherectomy for treatment of left anterior descending ostial stenosisEzio Bramucci
Department of Cardiology, I R C C S Policlinico San Matteo, Piazzale Golgi 2, 27100 Pavia, Italy
Am J Cardiol 90:1074-8. 2002..These results indicate that the combined approach of DCA and stent implantation is feasible and safe in patients with LAD ostial lesions, has a high success rate, a low incidence of restenosis, and a good long-term outcome...
The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromesStefano Savonitto
Department of Cardiology, Niguarda Hospital, Milan, Italy
J Am Coll Cardiol 39:22-9. 2002..The study investigated the relationship among creatine kinase (CK) elevations, clinical characteristics and cardiac events across the whole spectrum of acute coronary syndromes (ACS)...
Plasma and urinary free 3-nitrotyrosine following cardiac angiography procedures with non-ionic radiocontrast mediaEnrico Fiaccadori
Dipartimento di Clinica Medica, Nefrologia e Scienze della Prevenzione, Universita degli Studi di Parma, Via Gramsci 14, 43100 Parma, Italy
Nephrol Dial Transplant 19:865-9. 2004..However, no study has been published showing that RCM administration elicits oxidative stress in humans...
Risk of myocardial infarction and polymorphisms in candidate genesPier M Mannucci
N Engl J Med 348:1176-7; author reply 1176-7. 2003
[Guidelines on the management of stable angina pectoris; the experts of the European Society of Cardiology on the management of stable angina pectoris]Kim Fox
Department of Cardiology, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK
Kardiol Pol 64:823-80. 2006
Expression of endothelial protein C receptor and thrombomodulin in human coronary atherosclerotic plaquesPiera Angelica Merlini
Division of Cardiology, Niguarda Ca Granda Hospital, Milan, Italy
Ital Heart J 5:42-7. 2004....
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of CardiologyKim Fox
Department of Cardiology, Royal Brompton Hospital, London, UK
Eur Heart J 27:1341-81. 2006
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantationUmberto Canosi
Divisione di Cardiologia IRCCS Policlinico San Matteo, Piazza Golgi 2, 27100 Pavia, Italy
Thromb Haemost 91:795-800. 2004..Our results indicate that ACE I/D polymorphism does not influence the risk of developing angiographic restenosis in patients undergoing DCA followed by stent implantation...
Images in cardiovascular medicine. Magnetic resonance imaging of impending left ventricular rupture after acute myocardial infarctionAntonello Zoni
Division of Cardiology, University Hospital, Parma, Italy
Circulation 108:498-9. 2003
Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trialDiego Ardissino
Division of Cardiology, Ospedale Maggiore, University of Parma, Italy
JAMA 292:2727-34. 2004..Sirolimus-eluting stents reduce restenosis in simple and previously untreated lesions of large coronary arteries, but their outcomes in small vessels have not been adequately investigated...
[Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]Jose Lopez-Sendon
Rev Esp Cardiol 57:1213-32. 2004
Effectiveness of treatment of in-stent restenosis with an 8-French compatible atherectomy catheterFlavio Airoldi
EMO Centro Cuore, Columbus Clinic, Via Buonarroti 48 20145 Milan, Italy
Am J Cardiol 92:725-8. 2003..6% of patients. The secondary end point regarding the incidence of angiographic restenosis at 6 months showed a high restenosis rate (65%)...
Vagaries of genetic association studies in myocardial infarctionPier M Mannucci
Blood 102:1558-9; author reply 1559-60. 2003
Effect of sirolimus-eluting stent in diabetic patients with small coronary arteries (a SES-SMART substudy)Paolo Ortolani
Institute of Cardiology, Policlinico S Orsola, University of Bologna, Bologna, Italy
Am J Cardiol 96:1393-8. 2005..In conclusion, in diabetics with small coronary arteries, SES implantation significantly reduces the incidence of the 8-month angiographic restenosis rate compared with BMSs...
The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer sizeJeffrey I Zwicker
Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
Blood 108:1280-3. 2006....
Usefulness of 64-slice multislice computed tomography coronary angiography to assess in-stent restenosisFilippo Cademartiri
Department of Radiology and Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
J Am Coll Cardiol 49:2204-10. 2007..This study sought to evaluate the diagnostic accuracy of 64-slice multislice computed tomography (MSCT) coronary angiography in the follow-up of patients with previous coronary stent implantation...
